Immunomodulatory effect of Nigella sativa oil in the disease process of type 1 diabetic rats

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Volumn 4, Issue 1, 2013, Pages 980-988

  Hmza, Afaf Jamal Ali ^a   Osman, Muhamed T ^a   Adnan, Ariza ^a   Omar, Effat ^a  

^a Faculty of Veterinary Medicine   (Malaysia)

Author keywords

Anti islet cell antibody; CD markers; Nigella sativa; Serum insulin; Type1 diabetes mellitus

Indexed keywords

CD11B ANTIGEN; CD19 ANTIGEN; GLUCOSE; IMMUNOMODULATING AGENT; INSULIN; NIGELLA SATIVA OIL; PANCREAS ISLET CELL ANTIBODY; THY 1 ANTIGEN; UNCLASSIFIED DRUG; VEGETABLE OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; BLACK CUMIN; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMUNOMODULATION; INNATE IMMUNITY; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LOW DRUG DOSE; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES;

EID: 84874705433     PISSN: None     EISSN: 09758585     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Didier H, Famara S. Dicov Med 2010; 10(51): 151-61.
2. Amirshahrokhi K, Dehpour AR, Hadjati BJ. Sotoudeh M, Ghazi-Khansari M. Toxicol App Pharmacol 2008; 232: 119-124.
3. Atkinson MA, Maclaren NK. New England J Med 1994; 331: 1428-1436.
4. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth, GS. Diabetes 1996; 45: 926-933.
5. Kulmala P, Rahko J, Savola K, Vahasalo P, Sjoroos M, Reunanen A, Ilonen J, Knip M Diabetes Care 2001; 24: 171-173.
6. Landin-Olsson M, Palmer JP, Lernmark A, Blom L, Sundkvist G, Nystrom L, Dahlquist G. Diabetologia 1992; 35: 1068-1073.
7. Myers MA, Rabin DU, Rowley MJ. Diabetes 1995; 44: 1290-1295.
8. Kulmala P, Savola K, Petersen JS, Vahasalo P, Karjalainen J, Lopponen T, Dyrberg T, Akerblom HK, Knip M. J Clin Inv 1998; 101: 327-336.
9. Mahmoud, Abu Abeeleh, Zuhair BI, Khaled R, Alzaben, Sami A, Abu-Halaweh MK, Al-Essa, Moaath M. European J Sci Res 2009; 32 :398-402.
10. Szkudelski T. Physiol Res 2001; 50: 537-546.
11. Aly HF, Mantawy MM. European Rev Med Pharmacol Sci 2012; 16: 66-78.
12. Mahiuddin A, and Shaikh JU. Ethnomedicine: A Source of Complementary Therapeutics 2010; 227-244
13. Tapsell LC, Hemphill I, Cobiac L, Patch CS, Sullivan DR, Fenech M, Roodenrys S, Keogh JB, Clifton PM, Williams PG, Fazio VA, Inge KE. Med J Aust 2006;185(4):4-24.
14. Ilaiyaraja N, Khanum F. Journal of Herbal Medicine and Toxicology 2010; 4 (2): 1-8.
15. El-Dakhakhny M, Barakat M, El-Halim MA, Aly SM. J Ethanophormacol 2000;72: 299-304.
16. Al-Ghamdi MS. Am J Chin Med 2003; 31 :721-728.
17. Nadia, M Hamdy RA, Taha B. Pharmacology 2009; 84: 127-134.
18. Mehmet K. Ti{dotless}p Araşti{dotless}rmalari{dotless} Dergisi. 2009; 7 :64-70.
19. El-Dakhakhny M, N Mady, N Lembert and HP Ammon. Planta Med 2002; 68: 465-466.
20. Kanter MO. Coskun A, Korkomaz and S Oter. Anat Rec A Discov Mol Cell Evol Bio 2004; 279: 685-691.
21. Kulmala P, Rahko J, Savola K, Vahasalo P, Sjoroos M, Reunanen A, Ilonen J, Knip M. Diabetes Care 2001; 24: 171-173.
22. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth, GS. Diabetes 1996; 45: 926-933.
23. Houghton PJ, Zarka R, De las Heras B, Hoult RS. Planta Medica 1995; 61:33-6.
24. Haq A, Adbullatif M, Labo P, Khabar K, Sheth K, AlSedairy S. Immunopharmacology 1995; 30:147-55.
25. Swamy SM, Tan BK. J Ethnopharmacol 2000; 70: 1-7.
26. Islam SN, Begum P, Ahsan T, Huque S, Ahsan M. Phytother Res 2004; 18:395-8.
27. Mohamed LS. International Immunopharmacology 2005; 5: 1749-1770.